The 20 Best Castleman Disease Doctors near San Francisco, CA

Alan Kramer is an Oncologist in San Francisco, California. Dr. Kramer is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Nasopharyngeal Carcinoma, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Kramer is currently accepting new patients.

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Chia-Ching Wang, who goes by Jackie, is an oncologist who treats anal cancer. She also provides cancer screenings with high-resolution anoscopy (an examination using an instrument that can be inserted into the anal canal). Wang's work in research focuses on HIV oncology, particularly HPV-related cancers. (HIV-infected individuals may be at higher risk for developing HPV-related cancers due to their immunosuppression. She hopes to develop and implement prevention strategies, as well as test novel therapies that may improve outcomes for patients with these cancers.) She has also completed studies on lymphoma and Kaposi's sarcoma. She has special interests in superficially invasive squamous cell carcinoma of the anus and in post-treatment surveillance. Wang received her medical degree from the State University of New York at Stony Brook. She began a residency in obstetrics and gynecology at Women & Infants Hospital of Rhode Island, but after the first year, she decided to change her focus to HIV-related work. She subsequently completed a research fellowship at the Miriam Hospital, a teaching affiliate of the Warren Alpert Medical School of Brown University. She then completed a residency in internal medicine at Brown University. After working for a year as a hospitalist (a physician dedicated to patient care in the hospital setting), she came to UCSF for a fellowship in hematology and oncology. Wang is a member of the American Society of Hematology, American Society of Clinical Oncology and American Medical Association. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Anal Cancer, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Lung Cancer.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Catherine Smith is a hematologist-oncologist who cares for patients with acute leukemia and myeloproliferative neoplasms (blood cancers that occur when the body overproduces one of the blood cell types). She specializes in acute myeloid leukemia (also known as acute myelogenous leukemia or AML), a cancer of the blood and bone marrow that spreads rapidly. She has a particular interest in treating AML patients who have mutations in the FLT3 gene, which is involved in leukemia cell growth, division and survival and is a factor that may be useful in making a prognosis. Smith's research focuses on understanding why some patients do not respond to AML therapies and on developing new strategies to treat these patients. A San Francisco native, Smith earned her medical degree from Duke University and completed a residency in internal medicine at Brigham and Women's Hospital. She then completed a fellowship in hematology and oncology at UCSF. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Essential Thrombocythemia, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Myelofibrosis, and Bone Marrow Aspiration.

Dr. Peter Sayre specializes in adult bone marrow transplantation and other treatments for leukemia, multiple myeloma, lymphoma and Hodgkin's disease. Sayre is a director of clinical research at UCSF. His research interests focus on allogeneic stem cell transplants (which use cells from a matching donor) and leukemia in older adults. His work on these subjects has been widely published in medical and other scientific journals. Sayre earned an undergraduate degree in philosophy from Yale College, graduating magna cum laude. He earned his medical degree at the Rutgers Robert Wood Johnson Medical School, and he earned a doctorate in immunology at Harvard University. He completed a fellowship in hematology and oncology at UCSF before joining the faculty in 1996. Dr. Sayre is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Michael Spinner is a Hematologist in San Francisco, California. Dr. Spinner is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Wei Wang is an Oncologist in San Francisco, California. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Ajai Chari is an Oncologist in San Francisco, California. Dr. Chari is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Lloyd Damon is an Oncologist in San Francisco, California. Dr. Damon has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Oleg Krijanovski is a Hematologist in Berkeley, California. Dr. Krijanovski is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is currently accepting new patients.

Dr. Kent Adler is an oncologist experienced in treating a variety of cancers, with particular expertise in lung and breast cancer. He believes three pillars form the strongest foundation to fight cancer: knowledge, communication and heart. Adler's research focuses on developing new therapies for lung cancer. Adler earned his medical degree from UCSF. He completed a residency in internal medicine at New York – Presbyterian/Weill Cornell Medical Center and a fellowship in medical oncology at Stanford University School of Medicine. A longtime advocate of multidisciplinary clinics for managing cancer, he co-founded one of the first multidisciplinary clinics for lung cancer on the West Coast while a faculty member at Stanford. Throughout his career, Adler has served in leadership positions, including as a board member of the Mills Peninsula Medical Group and Association of Northern California Oncologists. In his free time, Adler enjoys traveling, skiing and hiking with his wife, also a doctor, and their two adult children. A native of the Bay Area, he also loves the San Francisco Giants and almost anything related to baseball. Dr. Adler is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Large-Cell Immunoblastic Lymphoma.

Anjali Sibley is a Hematologist in Emeryville, California. Dr. Sibley is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Anemia, Adenoid Cystic Carcinoma, Acinic Cell Carcinoma of Salivary Glands, and Salivary Gland Tumors.

Lisa Montang is a primary care provider, practicing in Family Medicine in Oakland, California. Dr. Montang is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Sadia Zafar is a primary care provider, practicing in Internal Medicine in Oakland, California. Dr. Zafar has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Ascites, Lymphofollicular Hyperplasia, Lymphoid Hyperplasia, and Epidural Lipomatosis. Dr. Zafar is currently accepting new patients.